Byron Nash Renal Medullary Carcinoma Awareness Act of 2023

Introduced Jan 3, 2025Latest action Jan 3, 2025Health

Plain-English summary

Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [ sic ] This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait. )

Deterministically condensed from the official CRS summary; verify details in the official record.

Issue relevance

Why this appears in Paper Trail

Healthcare

Matched from official metadata: policy_area: Health

People and recorded decisions

Sponsors, Cosponsors & House Votes

Alexander Green

Sponsor · Democratic · TX

No linked House roll-call vote is available yet. Senate votes are not currently synchronized.

Official Subjects

HealthCancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid

Sources & text

Official Congress.gov record ↗Introduced in House ↗Introduced in House ↗Introduced in House ↗

Congress.gov data last updated Sep 9, 2026. Automated summaries preserve a source version and generation timestamp; human edits are explicitly recorded.